New Report Sheds Light on Effectiveness of Federal Government’s Response to Need for COVID-19 Testing
...
Already a member? Log in here
Focus On-nir
Subscribe today for access to
Articles and Reports
January 1, 2021 Is D-Day for Hospital Pricing Transparency
...
Already a member? Log in here
Surviving PAMA: Keep an Eye on Industry Disruptors
...
Already a member? Log in here
New Project Aims to Provide Legal Guidance Needed to Do Business in Genomics
From - National Intelligence Report
Technology changes faster than the laws designed to regulate it. Thus, while DNA testing has changed medicine and fueled growth in…
DOJ Explains What It Wants from a Compliance Program
...
Already a member? Log in here
Genomic Data Sharing: From Utopian Principle to Practical Reality
From - National Intelligence Report
As a principle, it's hard to take issue with Science's recommendation; but as the article itself notes, actually achieving genomic data sharing remains…
Medicare Reimbursement: New Guidance on Date of Service Rules for Part B Billing of Hospital Outpatient Lab Tests
...
Already a member? Log in here
How the Opioid Crackdown Is Affecting Lab Enforcement & Test Utilization
From - National Intelligence Report
The alarming finding that a person is now more statistically likely to die of an opioid overdose than a motor vehicle crash comes from…
The Worker Shortage and Your Lab
...
Already a member? Log in here
New Broad All-Payor Kickback Law Impacting Laboratories, Commission-based Compensation and more
LDTs: FDA Announces New Approach to 510(k) Approvals
From - National Intelligence Report
Last month, the FDA floated a plan to overhaul and modernize the 510(k) premarket review pathway allowing for faster, safer approval of medical devices, including…
Medicare Reimbursement: CMS Provides Needed PAMA Relief—But Newly Covered Hospital Labs Must Report in 2019
From - National Intelligence Report
The battle between CMS and the lab industry over Medicare Part B pricing for lab tests could be on the road to…
